Dose Range Finding Study of Fedovapagon in Men With Nocturia
Public ClinicalTrials.gov record NCT01656239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Dose Range Finding Study To Determine The Efficacy And Safety Of Fedovapagon In Men With Nocturia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the dose level(s) of fedovapagon which result in a decrease in the mean nocturnal void frequency.
Study identification
- NCT ID
- NCT01656239
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 358 participants
Conditions and interventions
Conditions
Interventions
- fedovapagon 1 mg Drug
- fedovapagon 2 mg Drug
- fedovapagon 4 mg Drug
- Placebo ( sugar pill) Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2012 (Type not available)
- Primary completion
- Aug 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Jun 20, 2014
2012 – 2013
United States locations
- U.S. sites
- 56
- U.S. states
- 30
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vantia Investigative Center | Birmingham | Alabama | — | — |
| Vantia Investigative Center | Huntsville | Alabama | — | — |
| Vantia Investigative Center | Mobile | Alabama | — | — |
| Vantia Investigative Center | Glendale | Arizona | — | — |
| Vantia Investigative Center | Tucson | Arizona | — | — |
| Vantia Investigative Center | Anaheim | California | — | — |
| Vantia Investigative Center | Long Beach | California | — | — |
| Vantia Investigative Center | San Diego | California | — | — |
| Vantia Investigative Center | Denver | Colorado | — | — |
| Vantia Investigative Center | Englewood | Colorado | — | — |
| Vantia Investigative Center | Milford | Connecticut | — | — |
| Vantia Investigative Center | Aventura | Florida | — | — |
| Vantia Investigative Center | Clearwater | Florida | — | — |
| Vantia Investigative Center | Daytona Beach | Florida | — | — |
| Vantia Investigative Center | DeLand | Florida | — | — |
| Vantia Investigative Center | Naples | Florida | — | — |
| Vantia Investigative Center | Ocala | Florida | — | — |
| Vantia Investigative Center | St. Petersburg | Florida | — | — |
| Vantia Investigative Center | Tampa | Florida | — | — |
| Vantia Investigative Center | Coeur d'Alene | Idaho | — | — |
| Vantia Investigative Center | Meridian | Idaho | — | — |
| Vantia Investigative Center | Chicago | Illinois | — | — |
| Vantia Investigative Center | Evansville | Indiana | — | — |
| Vantia Investigative Center | Jeffersonville | Indiana | — | — |
| Vantia Investigative Center | Paducah | Kentucky | — | — |
| Vantia Investigative Center | Metairie | Louisiana | — | — |
| Vantia Investigative Center | Greenbelt | Maryland | — | — |
| Vantia Investigative Center | Rochester | Michigan | — | — |
| Vantia Investigative Center | Edina | Minnesota | — | — |
| Vantia Investigative Center | Omaha | Nebraska | — | — |
| Vantia Investigative Center | Brick | New Jersey | — | — |
| Vantia Investigative Center | Englewood | New Jersey | — | — |
| Vantia Investigative Center | Lawrenceville | New Jersey | — | — |
| Vantia Investigative Center | Albuquerque | New Mexico | — | — |
| Vantia Investigative Center | Brooklyn | New York | — | — |
| Vantia Investigative Center | Endwell | New York | — | — |
| Vantia Investigative Center | Garden City | New York | — | — |
| Vantia Investigative Center | New York | New York | — | — |
| Vantia Investigative Center | Poughkeepsie | New York | — | — |
| Vantia Investigative Center | Concord | North Carolina | — | — |
| Vantia Investigative Center | Raleigh | North Carolina | — | — |
| Vantia Investigative Center | Winston-Salem | North Carolina | — | — |
| Vantia Investigative Center | Cincinnati | Ohio | — | — |
| Vantia Investigative Center | Bethany | Oklahoma | — | — |
| Vantia Investigative Center | Bala-Cynwyd | Pennsylvania | — | — |
| Vantia Investigative Center | Warwick | Rhode Island | — | — |
| Vantia Investigative Center | Mytrle Beach | South Carolina | — | — |
| Vantia Investigative Center | Dakota Dunes | South Dakota | — | — |
| Vantia Investigative Center | Nashville | Tennessee | — | — |
| Vantia Investigative Center | Dallas | Texas | — | — |
| Vantia Investigative Center | Fort Worth | Texas | — | — |
| Vantia Investigative Center | San Antonio | Texas | — | — |
| Vantia Investigative Center | Richmond | Virginia | — | — |
| Vantia Investigative Center | Virginia Beach | Virginia | — | — |
| Vantia Investigative Center | Burien | Washington | — | — |
| Vantia Investigative Center | Middleton | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01656239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 20, 2014 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01656239 live on ClinicalTrials.gov.